Tyr537
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.4
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr537  -  Yes (human)

Site Information
FtAtEPQyQPGENL_   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447620
Available spectra:  3 CST
Associated spectra:  14 CST

In vivo Characterization
Methods used to characterize site in vivo:
2D analysis ( 1173 ) , mass spectrometry ( 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1132 , 1133 , 1134 , 1135 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1167 , 1168 , 1169 , 1170 , 1171 ) , mutation of modification site ( 1172 ) , phospho-antibody ( 1005 , 1172 ) , phosphopeptide mapping ( 1173 ) , western blotting ( 1005 , 1172 , 1173 )
Disease tissue studied:
atrial fibrillation ( 795 , 796 , 806 , 807 , 808 , 809 ) , adenoid cystic carcinoma ( 629 , 631 ) , bile-duct cancer ( 28 , 29 , 567 , 569 , 610 ) , bladder cancer ( 251 , 252 , 253 , 1004 , 1005 , 1028 ) , bladder cancer, surrounding tissue ( 242 , 250 ) , bone cancer ( 866 , 867 , 868 , 899 , 900 , 901 , 902 ) , Ewing's sarcoma ( 900 ) , osteosarcoma ( 866 , 867 , 868 , 899 , 901 , 902 ) , brain cancer ( 14 , 53 , 64 , 603 , 691 , 830 , 831 , 832 , 856 , 1056 , 1097 , 1098 , 1119 ) , astrocytoma ( 53 , 64 , 603 , 1119 ) , glioblastoma ( 1056 , 1097 , 1098 ) , glioblastoma multiforme ( 14 , 691 , 830 , 831 , 832 , 856 , 1056 , 1098 ) , glioma ( 14 , 691 , 830 , 831 , 832 , 856 , 1056 , 1097 , 1098 ) , breast cancer ( 11 , 232 , 233 , 234 , 235 , 236 , 240 , 241 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 395 , 396 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 797 , 810 , 851 , 854 , 855 , 909 , 910 , 913 , 1000 , 1001 , 1009 , 1014 , 1016 , 1017 , 1029 , 1041 , 1042 , 1096 , 1099 , 1108 , 1109 , 1137 , 1167 , 1168 , 1169 , 1170 ) , breast adenocarcinoma ( 1017 , 1167 , 1168 , 1169 , 1170 ) , breast ductal carcinoma ( 1096 , 1099 ) , breast cancer, surrounding tissue ( 233 , 235 , 240 , 243 , 244 , 245 , 248 , 810 ) , breast cancer, triple negative ( 1099 ) , colorectal cancer ( 34 , 35 , 52 , 60 , 61 , 492 , 493 , 497 , 498 , 500 , 509 , 510 , 541 , 751 , 754 , 759 , 760 , 764 , 767 , 769 , 891 , 892 , 893 , 906 , 1107 , 1159 , 1160 , 1161 , 1173 ) , colorectal carcinoma ( 34 , 35 , 52 , 60 , 61 , 1107 , 1159 , 1160 , 1161 , 1173 ) , colorectal cancer, surrounding tissue ( 494 , 496 , 499 , 501 , 508 , 511 , 539 , 542 , 543 , 544 , 547 , 686 , 750 , 753 , 755 , 761 , 765 , 768 , 770 , 771 ) , esophageal cancer ( 152 , 153 , 154 , 386 , 404 , 406 , 407 , 409 , 410 , 412 , 417 , 418 , 422 , 423 , 426 , 427 , 428 , 429 , 432 , 433 , 434 , 436 , 440 , 441 , 445 , 448 , 449 , 450 , 454 , 455 , 456 , 459 , 461 , 462 , 465 , 466 , 467 , 476 , 477 , 478 , 479 , 481 , 484 , 1030 , 1031 , 1032 , 1033 , 1034 ) , esophageal carcinoma ( 152 , 153 , 154 , 1030 , 1031 , 1034 ) , esophageal cancer, surrounding tissue ( 403 , 405 , 408 , 411 , 413 , 414 , 415 , 416 , 419 , 420 , 421 , 424 , 425 , 430 , 431 , 435 , 437 , 438 , 439 , 442 , 443 , 444 , 446 , 447 , 451 , 452 , 453 , 457 , 458 , 460 , 463 , 464 , 468 , 470 , 471 , 472 , 473 , 474 , 475 , 480 , 482 , 483 , 486 , 487 ) , gallbladder cancer ( 824 ) , gastric cancer ( 22 , 23 , 24 , 41 , 42 , 62 , 63 , 142 , 143 , 144 , 145 , 146 , 188 , 189 , 192 , 194 , 205 , 207 , 208 , 212 , 213 , 216 , 217 , 218 , 622 , 641 , 643 , 645 , 646 , 648 , 650 , 652 , 655 , 657 , 659 , 661 , 663 , 665 , 667 , 671 , 672 , 673 , 678 , 679 , 680 , 799 , 801 , 813 , 816 , 817 , 822 , 825 , 826 , 827 , 828 , 829 , 836 , 838 , 845 , 846 , 847 , 848 , 849 , 857 , 920 , 921 , 952 , 1010 , 1011 , 1053 , 1054 , 1055 , 1057 ) , gastric carcinoma ( 41 , 42 , 62 , 63 , 142 , 143 , 144 , 145 , 146 , 192 , 194 , 205 , 641 , 643 , 645 , 646 , 648 , 650 , 652 , 655 , 657 , 659 , 661 , 663 , 665 , 667 , 799 , 801 , 817 , 822 , 857 , 920 , 921 , 952 , 1054 ) , gastric carcinoma, surrounding tissue ( 206 , 209 , 210 , 211 , 214 , 215 , 219 , 640 , 642 , 644 , 647 , 649 , 651 , 653 , 654 , 656 , 658 , 660 , 662 , 664 , 666 , 670 , 674 , 676 , 677 , 681 , 798 , 800 , 814 , 815 , 823 , 837 , 839 ) , kidney cancer ( 274 , 275 , 298 , 300 ) , kidney cancer, surrounding tissue ( 255 , 258 , 259 , 276 , 297 , 299 , 301 ) , laryngeal cancer ( 780 , 781 , 782 , 783 , 879 , 880 , 881 , 882 , 907 , 908 , 916 , 917 ) , laryngeal cancer, surrounding tissue ( 784 ) , leukemia ( 36 , 37 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 157 , 158 , 159 , 161 , 162 , 166 , 167 , 168 , 170 , 172 , 173 , 175 , 193 , 197 , 224 , 225 , 226 , 227 , 237 , 238 , 239 , 265 , 266 , 267 , 268 , 363 , 364 , 365 , 369 , 370 , 371 , 373 , 392 , 394 , 552 , 553 , 554 , 557 , 558 , 559 , 560 , 778 , 779 , 785 , 802 , 803 , 820 , 835 , 844 , 850 , 889 , 890 , 894 , 895 , 896 , 897 , 898 , 903 , 904 , 905 , 915 , 926 , 927 , 931 , 933 , 934 , 935 , 936 , 939 , 940 , 941 , 942 , 947 , 948 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 1006 , 1007 , 1008 , 1012 , 1013 , 1020 , 1021 , 1027 , 1049 , 1050 , 1051 , 1062 , 1063 , 1064 , 1065 , 1068 , 1069 , 1070 , 1072 , 1073 , 1077 , 1078 , 1079 , 1080 , 1083 , 1084 , 1085 , 1086 , 1088 , 1089 , 1090 , 1091 , 1105 , 1110 , 1111 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1144 , 1145 , 1146 , 1147 ) , acute lymphocytic leukemia ( 117 , 1020 , 1072 , 1073 , 1079 , 1080 , 1111 , 1126 , 1127 , 1129 , 1130 ) , acute myelogenous leukemia ( 915 , 939 , 940 , 941 , 942 , 947 , 948 , 953 , 954 , 955 , 956 , 957 , 961 , 962 , 1012 , 1013 , 1021 , 1077 , 1078 , 1083 , 1084 , 1085 , 1086 , 1089 , 1090 , 1091 , 1105 , 1110 , 1144 , 1145 , 1146 , 1147 ) , chronic lymphocytic leukemia ( 1088 , 1128 ) , chronic myelogenous leukemia ( 36 , 37 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 157 , 158 , 159 , 161 , 162 , 166 , 167 , 168 , 170 , 172 , 173 , 175 , 193 , 197 , 224 , 225 , 226 , 227 , 237 , 238 , 239 , 265 , 266 , 267 , 268 , 363 , 364 , 365 , 369 , 370 , 371 , 373 , 392 , 394 , 552 , 553 , 554 , 557 , 558 , 559 , 560 , 778 , 779 , 785 , 802 , 803 , 820 , 835 , 844 , 850 , 894 , 895 , 896 , 897 , 898 , 903 , 904 , 905 , 926 , 927 , 931 , 933 , 934 , 935 , 936 , 958 , 959 , 960 , 963 , 964 , 965 , 1006 , 1007 , 1008 , 1027 , 1049 , 1050 , 1051 , 1062 , 1063 , 1064 , 1065 , 1068 , 1069 , 1070 , 1124 , 1125 ) , liver cancer ( 116 , 260 , 261 , 305 , 307 , 309 , 315 , 316 , 317 , 318 , 319 , 320 , 322 , 323 , 324 , 325 , 326 , 327 , 329 , 330 , 332 , 333 , 335 , 336 , 340 , 341 , 343 , 344 , 345 , 351 , 353 , 354 , 356 , 357 , 358 , 362 , 368 , 495 , 518 , 519 , 521 , 522 , 523 , 540 , 566 , 568 , 605 , 608 , 609 , 611 , 688 , 689 , 690 , 721 , 724 , 729 , 731 , 732 , 734 , 735 , 737 , 738 , 739 , 742 , 743 , 747 , 749 ) , cholangiocellular carcinoma ( 116 , 316 , 340 , 357 , 519 , 522 , 540 , 734 , 742 ) , cholangiocellular carcinoma, surrounding tissue ( 314 , 338 , 525 , 537 , 840 , 843 ) , hepatocellular carcinoma ( 305 , 307 , 309 , 315 , 317 , 318 , 319 , 320 , 326 , 327 , 329 , 330 , 332 , 333 , 335 , 336 , 341 , 343 , 344 , 345 , 351 , 356 , 358 , 362 , 368 , 523 , 688 , 721 , 724 , 729 , 731 , 732 , 735 , 739 , 747 , 749 ) , hepatocellular carcinoma, surrounding tissue ( 306 , 308 , 310 , 321 , 328 , 331 , 334 , 337 , 339 , 342 , 346 , 347 , 348 , 349 , 352 , 355 , 360 , 361 , 520 , 524 , 536 , 538 , 722 , 728 , 730 , 733 , 740 , 748 , 841 , 842 ) , liver cancer, surrounding tissue ( 254 , 256 , 257 , 350 , 359 , 741 ) , lung cancer ( 5 , 6 , 7 , 8 , 9 , 10 , 12 , 13 , 16 , 17 , 18 , 19 , 20 , 21 , 48 , 49 , 50 , 51 , 54 , 55 , 56 , 57 , 58 , 59 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 82 , 102 , 137 , 151 , 163 , 165 , 174 , 180 , 181 , 185 , 186 , 205 , 280 , 285 , 286 , 296 , 302 , 372 , 374 , 375 , 376 , 377 , 378 , 380 , 381 , 383 , 387 , 388 , 389 , 390 , 502 , 503 , 504 , 505 , 506 , 507 , 512 , 514 , 517 , 526 , 527 , 548 , 549 , 550 , 551 , 555 , 595 , 604 , 607 , 614 , 616 , 617 , 624 , 626 , 669 , 683 , 684 , 685 , 696 , 697 , 699 , 762 , 763 , 811 , 812 , 818 , 819 , 821 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 912 , 914 , 922 , 923 , 924 , 925 , 928 , 929 , 930 , 949 , 950 , 951 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 997 , 998 , 999 , 1015 , 1018 , 1022 , 1023 , 1024 , 1035 , 1036 , 1038 , 1040 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1052 , 1066 , 1074 , 1075 , 1087 , 1095 , 1101 , 1102 , 1103 , 1104 , 1106 , 1112 , 1113 , 1114 , 1118 , 1121 , 1122 , 1123 , 1131 , 1135 , 1136 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1164 , 1165 ) , non-small cell lung cancer ( 5 , 6 , 7 , 9 , 10 , 12 , 16 , 17 , 18 , 19 , 20 , 21 , 48 , 49 , 50 , 51 , 54 , 55 , 56 , 57 , 58 , 59 , 66 , 67 , 68 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 82 , 137 , 180 , 181 , 185 , 186 , 280 , 285 , 286 , 296 , 302 , 372 , 374 , 375 , 376 , 377 , 389 , 502 , 503 , 504 , 505 , 506 , 507 , 512 , 514 , 517 , 526 , 527 , 548 , 549 , 550 , 551 , 595 , 604 , 607 , 617 , 624 , 669 , 683 , 696 , 697 , 699 , 762 , 763 , 811 , 812 , 818 , 819 , 821 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 912 , 914 , 922 , 923 , 924 , 925 , 928 , 929 , 930 , 949 , 950 , 951 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 997 , 998 , 999 , 1015 , 1018 , 1022 , 1023 , 1024 , 1040 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1052 , 1066 , 1087 , 1101 , 1102 , 1103 , 1104 , 1106 , 1112 , 1121 , 1122 , 1123 , 1131 , 1135 , 1136 , 1139 , 1140 , 1141 , 1142 , 1164 , 1165 ) , non-small cell lung cancer, surrounding tissue ( 182 , 183 , 184 , 277 , 278 , 279 , 281 , 282 , 283 , 284 , 489 , 490 , 513 , 516 , 623 , 625 , 675 , 695 , 698 ) , non-small cell lung adenocarcinoma ( 5 , 6 , 7 , 8 , 9 , 10 , 12 , 13 , 48 , 49 , 50 , 51 , 56 , 57 , 58 , 59 , 66 , 67 , 68 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 82 , 137 , 205 , 296 , 302 , 372 , 374 , 375 , 376 , 502 , 503 , 504 , 505 , 548 , 549 , 550 , 551 , 604 , 683 , 762 , 763 , 922 , 923 , 928 , 929 , 930 , 950 , 951 , 1038 , 1121 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 81 , 618 , 627 , 682 ) , non-small cell large cell lung carcinoma ( 6 , 9 ) , non-small cell squamous cell lung carcinoma ( 8 , 69 , 205 , 378 , 380 , 381 , 383 , 387 , 388 , 390 , 502 , 503 , 504 , 505 , 555 , 684 , 685 , 922 , 923 , 1106 ) , small-cell lung cancer ( 1095 , 1113 , 1114 , 1118 , 1138 , 1143 ) , lung cancer, surrounding tissue ( 97 , 98 , 99 , 100 , 101 , 130 , 149 , 150 , 160 , 164 , 169 , 171 , 612 , 613 , 615 ) , neuroblastoma ( 2 , 123 , 124 , 125 , 126 , 127 , 128 , 589 , 590 , 591 , 592 , 593 , 702 , 703 , 704 , 710 , 711 , 1025 , 1026 , 1058 ) , ovarian cancer ( 26 , 27 , 104 , 118 , 119 , 120 , 121 , 122 , 131 , 132 , 133 , 134 , 135 , 155 , 187 , 190 , 191 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 869 , 872 , 873 , 874 , 875 , 876 , 883 , 884 , 885 , 886 , 887 , 888 , 1059 , 1060 , 1061 , 1071 ) , ovarian epithelial carcinoma ( 26 , 27 , 104 , 119 , 121 , 135 , 1059 , 1060 , 1061 , 1071 ) , pancreatic cancer ( 303 , 391 , 911 , 1148 , 1149 , 1150 , 1151 , 1152 , 1157 , 1158 , 1162 ) , pancreatic carcinoma ( 303 , 911 , 1149 , 1150 , 1157 , 1158 , 1162 ) , pancreatic cancer, surrounding tissue ( 393 ) , multiple myeloma ( 491 , 1081 , 1082 ) , prostate cancer ( 384 , 385 , 1153 , 1166 ) , salivary gland cancer ( 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 ) , melanoma skin cancer ( 545 , 546 , 561 , 562 , 563 , 564 , 565 , 596 , 597 , 598 , 599 , 600 , 687 , 694 , 709 ) , non-melanoma skin cancer ( 1154 , 1155 , 1156 , 1163 ) , teratoma ( 179 ) , teratoma, surrounding tissue ( 717 , 718 ) , thymic carcinoma ( 85 , 86 , 87 , 88 ) , thyroid cancer ( 1019 , 1037 ) , follicular thyroid carcinoma ( 1019 , 1037 ) , thyroid cancer, surrounding tissue ( 719 , 833 , 834 ) , ventricular tachycardia ( 89 , 90 , 91 , 92 , 93 , 94 , 105 , 106 )
Relevant cell line - cell type - tissue:
'heart, papillary muscle' ( 723 ) , 'liver, para-cholangiocellular carcinoma tissue' ( 116 ) , 143.98.2 (bone cell) ( 902 ) , 143B (bone cell) ( 868 ) , 23132/87 (gastric) [RAIG1 (human), knockdown] ( 22 , 23 ) , 23132/87 (gastric) ( 24 , 1054 ) , 293 (epithelial) [AT1 (human), transfection] ( 129 ) , 5637 (bladder cell) ( 1005 ) , A431 (epithelial) ( 1154 , 1155 , 1156 , 1163 ) , A549 (pulmonary) [LKB1 (human), no information] ( 763 ) , A549 (pulmonary) ( 5 , 13 , 372 , 762 ) , ACC-S (adenoidal) ( 628 , 630 ) , AGS (gastric) ( 1057 ) , AZ-521 (gastric) ( 827 ) , B lymphoid-blood ( 1088 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 530 , 531 ) , BEAS-2B (epithelial) ( 528 , 529 ) , bladder ( 242 , 250 , 251 , 252 , 253 ) , bone marrow ( 117 , 915 , 939 , 940 , 947 , 948 , 953 , 954 , 955 , 956 , 957 , 961 , 962 ) , brain ( 1056 ) , breast ( 232 , 233 , 234 , 235 , 236 , 240 , 241 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 797 , 810 , 851 , 854 , 855 , 909 , 910 , 913 , 1009 , 1014 , 1016 ) , BT-474 (breast cell) ( 395 ) , BV-173 (myeloid) ( 373 ) , BxPC-3 (pancreatic) ( 1148 , 1151 , 1152 ) , Cal-12T (pulmonary) ( 12 ) , CAL-148 (breast cell) ( 1029 ) , CAL-29 (bladder cell) ( 1004 ) , Calu-3 (pulmonary) ( 7 ) , cholangiocyte-liver ( 316 , 340 , 357 , 519 , 522 , 540 , 734 , 742 ) , CHRF (megakaryocyte) ( 1021 , 1105 ) , CMK (megakaryoblast) ( 1089 , 1090 , 1091 , 1144 ) , CMS (myeloid) ( 1013 ) , colon ( 492 , 493 , 494 , 496 , 497 , 498 , 499 , 500 , 501 , 508 , 509 , 510 , 511 , 539 , 541 , 542 , 543 , 544 , 547 , 686 , 750 , 751 , 753 , 754 , 755 , 759 , 760 , 761 , 764 , 765 , 767 , 768 , 769 , 770 , 771 , 891 , 892 , 893 , 906 ) , CTV-1 (myeloid) ( 1147 ) , DMS153 (pulmonary) ( 10 , 1092 , 1093 , 1094 , 1138 ) , DMS53 (pulmonary) ( 1114 ) , DMS79 (pulmonary) ( 1113 ) , DU.528 ('stem, hematopoietic') ( 1020 , 1079 , 1080 ) , DU4475 (breast cell) ( 1017 ) , DV-90 (pulmonary) ( 1036 ) , ES2 (ovarian) ( 1059 ) , esophagus ( 386 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 486 , 487 ) , EVSA-T (breast cell) ( 1041 ) , Flow2000 ( 1173 ) , FU97 (gastric) ( 188 , 189 , 828 ) , G-292 (bone cell) ( 899 ) , gallbladder ( 824 ) , germ cell-teratoma ( 717 , 718 ) , glial-brain ( 14 ) , HCC1143 (breast cell) ( 1099 ) , HCC1395 (breast cell) ( 1096 ) , HCC15 (pulmonary) ( 8 ) , HCC1599 (breast cell) ( 1000 , 1001 ) , HCC44 (pulmonary) ( 12 ) , HCC78 (pulmonary) ( 9 , 50 , 51 , 58 , 59 , 604 , 1015 ) , HCC827 (pulmonary) ( 7 , 137 , 374 , 950 , 951 , 1121 ) , HCT116 (intestinal) ( 34 , 35 , 52 , 60 , 61 , 367 , 1159 ) , heart ( 89 , 90 , 91 , 92 , 93 , 94 , 105 , 106 , 757 , 793 , 794 , 795 , 796 , 804 , 805 , 806 , 807 , 808 , 809 ) , HeLa (cervical) ( 3 , 195 , 196 , 693 , 705 , 706 , 707 , 708 ) , HeLa S3 (cervical) ( 720 ) , Hep 3B2.1-7 (hepatic) ( 609 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 314 , 338 , 525 , 537 , 840 , 843 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 306 , 308 , 310 , 321 , 328 , 331 , 334 , 337 , 339 , 342 , 346 , 347 , 348 , 349 , 352 , 355 , 360 , 361 , 520 , 524 , 536 , 538 , 722 , 728 , 730 , 733 , 740 , 748 , 841 , 842 ) , hepatocyte-liver ( 305 , 307 , 309 , 315 , 317 , 318 , 319 , 320 , 326 , 327 , 329 , 330 , 332 , 333 , 335 , 336 , 341 , 343 , 344 , 351 , 356 , 358 , 362 , 523 , 721 , 724 , 729 , 731 , 732 , 735 , 739 , 747 , 749 ) , HepG2 (hepatic) ( 368 ) , HOS (bone cell) ( 867 ) , HPAC (pancreatic) ( 303 ) , Hs746T (pancreatic) ( 1011 ) , Hs766T (pancreatic) ( 1150 ) , HT-29 (intestinal) ( 1107 , 1160 , 1161 , 1173 ) , HT-93 (myeloid) ( 1145 ) , Huh28 (hepatic) ( 608 ) , Huh6 (hepatic) ( 689 ) , Huh7 (hepatic) ( 690 ) , HUVEC (endothelial) ( 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 1115 , 1116 ) , IEC-18 (epithelial) ( 1172 ) , JHH-2 (hepatic) ( 611 ) , JHH-4 (hepatic) ( 566 ) , JHH-7 (hepatic) ( 605 ) , JIMT-1 (breast cell) ( 1042 ) , Jurkat (T lymphocyte) ( 15 , 30 , 31 , 32 , 33 , 44 , 45 , 46 , 47 , 65 , 83 , 84 , 95 , 96 , 103 , 138 , 139 , 140 , 141 , 147 , 148 , 156 , 176 , 177 , 220 , 221 , 222 , 223 , 228 , 229 , 230 , 231 , 262 , 263 , 264 , 269 , 270 , 271 , 272 , 273 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 304 , 311 , 312 , 313 , 366 , 379 , 382 , 397 , 398 , 515 , 534 , 535 , 556 , 594 , 601 , 602 , 668 , 700 , 701 , 712 , 713 , 714 , 715 , 716 , 725 , 736 , 744 , 745 , 746 , 758 , 766 , 852 , 853 , 864 , 870 , 871 , 877 , 918 , 919 , 932 , 996 , 1132 , 1133 , 1134 , 1171 ) , K562 (erythroid) ( 36 , 37 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 157 , 158 , 159 , 161 , 162 , 166 , 167 , 168 , 170 , 172 , 173 , 175 , 193 , 197 , 224 , 225 , 226 , 227 , 237 , 238 , 239 , 265 , 266 , 267 , 268 , 363 , 364 , 365 , 369 , 370 , 371 , 392 , 394 , 552 , 553 , 554 , 557 , 558 , 559 , 560 , 692 , 752 , 778 , 779 , 785 , 802 , 803 , 820 , 835 , 844 , 850 , 894 , 895 , 896 , 897 , 898 , 903 , 904 , 905 , 926 , 927 , 931 , 933 , 934 , 935 , 936 , 937 , 938 , 943 , 944 , 945 , 946 , 958 , 959 , 960 , 963 , 964 , 965 , 1006 , 1007 , 1008 , 1027 , 1049 , 1050 , 1051 , 1062 , 1063 , 1064 , 1065 , 1068 , 1069 , 1070 , 1100 , 1124 , 1125 ) , Kasumi-1 (myeloid) ( 1077 ) , KATO III (gastric) ( 1055 ) , KBM-3 (myeloid) ( 1146 ) , KELLY (neural crest) ( 2 , 1058 ) , kidney ( 255 , 258 , 259 , 274 , 275 , 276 , 297 , 298 , 299 , 300 , 301 ) , KPL-4 (breast cell) ( 11 ) , Kyse510 (esophageal) ( 153 ) , Kyse520 (esophageal) ( 152 , 1032 , 1033 ) , Kyse70 (esophageal) ( 154 , 1030 , 1031 , 1034 ) , LAN-6 (neural crest) ( 2 , 589 , 590 , 591 , 592 , 593 , 702 , 703 , 704 ) , larynx ( 780 , 781 , 782 , 783 , 784 , 879 , 880 , 881 , 882 , 907 , 908 , 916 , 917 ) , LCLC-103H (pulmonary) ( 1043 ) , liver ( 4 , 116 , 254 , 256 , 257 , 260 , 261 , 322 , 323 , 324 , 325 , 345 , 350 , 353 , 354 , 359 , 518 , 521 , 737 , 738 , 741 , 743 ) , LN18 (glial) ( 691 , 830 , 831 , 832 , 856 , 1098 ) , LNCaP (prostate cell) ( 384 , 385 , 1166 ) , LOU-NH91 (squamous) ( 8 ) , lung ( 5 , 6 , 7 , 8 , 9 , 10 , 12 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 97 , 98 , 99 , 100 , 101 , 102 , 130 , 149 , 150 , 160 , 163 , 164 , 165 , 169 , 171 , 174 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 378 , 380 , 381 , 383 , 387 , 388 , 389 , 390 , 489 , 490 , 506 , 507 , 512 , 513 , 514 , 516 , 517 , 548 , 549 , 550 , 551 , 555 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 623 , 624 , 625 , 626 , 627 , 669 , 675 , 682 , 683 , 684 , 685 , 695 , 696 , 697 , 698 , 699 , 811 , 812 , 818 , 819 , 821 , 858 , 859 , 860 , 861 , 862 , 863 , 912 , 914 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 997 , 998 , 999 , 1018 , 1022 , 1023 , 1024 , 1052 , 1066 , 1067 , 1074 , 1075 , 1117 , 1118 , 1120 ) , LXF-289 (pulmonary) ( 1044 ) , M059J (glial) ( 1097 ) , MCF-10A (breast cell) ( 1108 , 1109 , 1137 ) , MCF-7 (breast cell) ( 1167 ) , MDA-MB-361 (breast cell) ( 396 ) , MDA-MB-468 (breast cell) ( 1168 , 1169 , 1170 ) , MEC1 (B lymphocyte) ( 1128 ) , MG63 (bone cell) ( 866 ) , MIA PaCa-2 (pancreatic) ( 1157 , 1158 ) , MKN-45 (gastric) ( 41 , 42 , 62 , 63 , 142 , 143 , 144 , 145 , 146 , 192 , 194 , 205 , 621 , 622 , 857 , 920 , 921 , 952 ) , MKN-7 (gastric) ( 847 ) , MKN-74 (gastric) ( 848 ) , ML-1 [Human leukemia] (myeloid) ( 1019 , 1037 ) , MO-91 (myeloid) ( 1083 , 1084 ) , MOLT-15 (myeloid) ( 1111 ) , MV4-11 (macrophage) ( 367 , 485 , 488 , 942 , 1012 ) , myeloid-bone marrow ( 1085 , 1086 ) , NCCIT (epithelial) ( 179 ) , NCI-H1299 (pulmonary) ( 6 , 1101 ) , NCI-H1355 (pulmonary) ( 5 , 1035 ) , NCI-H1373 (pulmonary) ( 1164 ) , NCI-H1437 (pulmonary) ( 10 , 12 ) , NCI-H1650 (pulmonary) ( 7 , 16 , 17 , 18 , 19 , 20 , 21 , 54 , 55 , 376 , 1131 , 1139 ) , NCI-H1666 (pulmonary) ( 12 , 1141 ) , NCI-H1703 (squamous) ( 8 , 205 , 399 , 400 , 401 , 402 , 502 , 503 , 504 , 505 , 606 , 607 , 922 , 923 , 1165 ) , NCI-H1734 (pulmonary) ( 6 , 1142 ) , NCI-H1781 (pulmonary) ( 9 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 526 , 527 ) , NCI-H1792 (pulmonary) ( 5 , 532 , 533 ) , NCI-H1838 (pulmonary) ( 1047 ) , NCI-H1944 (pulmonary) ( 6 ) , NCI-H1975 (pulmonary) ( 7 , 375 , 857 , 1102 , 1135 , 1136 , 1140 ) , NCI-H2052 (pulmonary) ( 1045 ) , NCI-H2073 (pulmonary) ( 8 , 10 , 1048 ) , NCI-H209 (pulmonary) ( 10 ) , NCI-H2106 (pulmonary) ( 7 ) , NCI-H2172 (pulmonary) ( 1104 ) , NCI-H2228 (pulmonary) ( 9 , 1112 ) , NCI-H2286 (pulmonary) ( 1095 ) , NCI-H23 (pulmonary) ( 5 , 302 ) , NCI-H2342 (pulmonary) ( 8 , 1046 ) , NCI-H2347 (pulmonary) ( 1122 ) , NCI-H2405 (pulmonary) ( 12 ) , NCI-H2452 (pulmonary) ( 1040 ) , NCI-H292 (pulmonary) ( 151 ) , NCI-H3122 (pulmonary) ( 9 , 48 , 49 , 56 , 57 ) , NCI-H3255 (pulmonary) ( 205 , 377 , 619 , 620 , 857 , 924 , 925 , 949 , 1103 ) , NCI-H358 (pulmonary) ( 6 , 595 , 1123 ) , NCI-H441 (pulmonary) ( 5 , 296 ) , NCI-H460 (pulmonary) ( 6 ) , NCI-H520 (squamous) ( 1106 ) , NCI-H647 (pulmonary) ( 1087 ) , NCI-H661 (pulmonary) ( 9 ) , NCI-H69 (pulmonary) ( 1143 ) , NCI-H838 (pulmonary) ( 10 ) , NOMO-1 (myeloid) ( 941 ) , NT2 (testicular) ( 178 ) , NUGC-2 (gastric) ( 845 ) , NUGC-3 (gastric) ( 829 ) , NUGC-4 (gastric) ( 846 ) , OCUM-1 (gastric) ( 825 ) , OV90 (ovarian) ( 1061 ) , ovary ( 131 , 132 , 133 , 134 , 135 , 155 , 187 , 190 , 191 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 869 , 872 , 873 , 874 , 875 , 876 , 883 , 884 , 885 , 886 , 887 , 888 ) , OVKATE (ovarian) ( 118 , 120 ) , OVMANA (ovarian) [RAIG1 (human), knockdown] ( 26 ) , OVMANA (ovarian) ( 27 , 104 , 119 , 121 ) , OZ (bile-duct cell) [RAIG1 (human), knockdown] ( 28 , 29 ) , OZ (bile-duct cell) ( 610 ) , PANC-1 (pancreatic) ( 1162 ) , pancreas ( 391 , 393 , 911 ) , PC3 (prostate cell) ( 1153 ) , PC9 (pulmonary) ( 928 , 929 , 930 , 1039 ) , PC9-IR (pulmonary) ( 1038 ) , RERF-GC-1B (gastric) ( 826 ) , RMUG-S (ovarian) ( 122 ) , RWP1 (pancreatic) ( 1172 ) , SACC-83 (salivary gland) ( 629 , 631 ) , salivary gland ( 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 ) , SCH (gastric) ( 849 ) , SEM (B lymphocyte) ( 1072 , 1073 , 1126 , 1127 , 1129 , 1130 ) , SH-SY5Y (neural crest) ( 2 , 123 , 124 ) , SK-ES-1 ( 900 ) , SK-N-BE(2) (neural crest) ( 2 , 126 , 127 , 128 ) , skin ( 545 , 546 , 561 , 562 , 563 , 564 , 565 , 596 , 597 , 598 , 599 , 600 , 687 , 694 , 709 ) , SKNDZ (neural crest) ( 2 , 1025 ) , SKNFI (neural crest) ( 2 , 1026 ) , SKOV-3 (ovarian) ( 1060 , 1071 ) , SMS-KCN (neural crest) ( 2 , 710 , 711 ) , SMS-KCN-A (neural crest) ( 2 , 125 ) , SNU-1079 (hepatic) ( 569 ) , SNU-1196 (hepatic) ( 567 ) , SNU-16 (gastric) ( 1053 ) , SNU-182 (hepatic) ( 688 ) , SNU-398 (hepatic) ( 568 ) , SNU-449 (hepatic) ( 495 ) , SNU-5 (gastric) ( 1010 ) , stomach ( 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 670 , 671 , 672 , 673 , 674 , 676 , 677 , 678 , 679 , 680 , 681 , 798 , 799 , 800 , 801 , 813 , 814 , 815 , 816 , 817 , 822 , 823 , 836 , 837 , 838 , 839 ) , Su.86.86 (pancreatic) ( 1149 ) , T1-73 (bone cell) ( 901 ) , thymus ( 85 , 86 , 87 , 88 ) , thyroid ( 719 , 833 , 834 ) , U-118MG (glial) ( 53 , 64 , 603 , 1119 ) , U266 (plasma cell) ( 491 ) , UM-UC-1 (bladder cell) ( 1028 ) , UT-7 (myeloid) ( 1110 ) , WiDr (epithelial) ( 1173 ) , XG2 (B lymphocyte) ( 1081 ) , XG5 (B lymphocyte) ( 1082 ) , Z-55 (myeloid) ( 1078 )

Upstream Regulation
Kinases, in vitro:
CSK (human) ( 1076 )
Treatments:
serum_starvation ( 1005 ) , SII_angiotensin_2 ( 129 )

Downstream Regulation
Effects of modification on Yes:
enzymatic activity, inhibited ( 1172 )

References 

1

Guégan JP, et al. (2022) Signaling by the tyrosine kinase Yes promotes liver cancer development. Sci Signal 15, eabj4743
35041461   Curated Info

2

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

3

Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info

4

Bian Y, et al. (2014) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics 96, 253-62
24275569   Curated Info

5

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

6

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

7

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

8

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Tzouros M, et al. (2013) Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics. Mol Cell Proteomics 12, 3339-49
23882028   Curated Info

12

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

13

Johnson H, Lescarbeau RS, Gutierrez JA, White FM (2013) Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion. J Proteome Res 12, 1856-67
23438512   Curated Info

14

Johnson H, et al. (2012) Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics 11, 1724-40
22964225   Curated Info

15

Zhou J (2012) CST Curation Set: 14432; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

16

Possemato A (2012) CST Curation Set: 14060; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

17

Possemato A (2012) CST Curation Set: 14061; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

18

Possemato A (2012) CST Curation Set: 14062; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

19

Possemato A (2012) CST Curation Set: 14063; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

20

Possemato A (2012) CST Curation Set: 14058; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

21

Possemato A (2012) CST Curation Set: 14059; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

22

Tucker M (2012) CST Curation Set: 13492; Year: 2012; Biosample/Treatment: cell line, 23132/87[RAIG1(knockdown)]/GPRC5A knockdown; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

23

Tucker M (2012) CST Curation Set: 13493; Year: 2012; Biosample/Treatment: cell line, 23132/87[RAIG1(knockdown)]/GPRC5A knockdown; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

24

Tucker M (2012) CST Curation Set: 13494; Year: 2012; Biosample/Treatment: cell line, 23132/87/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

25

Possemato A (2012) CST Curation Set: 13560; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

26

Tucker M (2012) CST Curation Set: 13499; Year: 2012; Biosample/Treatment: cell line, OVMANA[RAIG1(knockdown)]/GPRC5A knockdown; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

27

Tucker M (2012) CST Curation Set: 13500; Year: 2012; Biosample/Treatment: cell line, OVMANA/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

28

Tucker M (2012) CST Curation Set: 13501; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

29

Tucker M (2012) CST Curation Set: 13502; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

30

Zhou J (2012) CST Curation Set: 12609; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

31

Zhou J (2012) CST Curation Set: 12610; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

32

Zhou J (2012) CST Curation Set: 12611; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

33

Zhou J (2012) CST Curation Set: 12612; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

34

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

35

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

36

Mulhern D (2011) CST Curation Set: 13266; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

37

Mulhern D (2011) CST Curation Set: 13267; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

38

Rikova K (2011) CST Curation Set: 13114; Year: 2011; Biosample/Treatment: cell line, MGH-2/unknown; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

39

Rikova K (2011) CST Curation Set: 13118; Year: 2011; Biosample/Treatment: cell line, MGH-6/unknown; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

40

Rikova K (2011) CST Curation Set: 13121; Year: 2011; Biosample/Treatment: cell line, MGH-9/unknown; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

41

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

42

Mulhern D (2011) CST Curation Set: 12853; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

43

Rexer BN, et al. (2011) Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene 30, 4163-74
21499296   Curated Info

44

Zhou J (2011) CST Curation Set: 12495; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

45

Zhou J (2011) CST Curation Set: 12496; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

46

Zhou J (2011) CST Curation Set: 12497; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

Moritz A (2011) CST Curation Set: 12258; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

48

Possemato A (2011) CST Curation Set: 11907; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

51

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

54

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

57

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

58

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

59

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Possemato A (2011) CST Curation Set: 11924; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

Possemato A (2011) CST Curation Set: 11925; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

65

Guo A (2011) CST Curation Set: 11646; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

Ren H (2011) CST Curation Set: 11772; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Ren H (2011) CST Curation Set: 11773; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

68

Ren H (2011) CST Curation Set: 11775; Year: 2011; Biosample/Treatment: cell line, RP92/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

69

Ren H (2011) CST Curation Set: 11776; Year: 2011; Biosample/Treatment: cell line, RP93/untreated; Disease: non-small cell squamous cell lung carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

70

Ren H (2011) CST Curation Set: 11777; Year: 2011; Biosample/Treatment: cell line, RP94/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

Ren H (2011) CST Curation Set: 11778; Year: 2011; Biosample/Treatment: cell line, RP95/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Ren H (2011) CST Curation Set: 11779; Year: 2011; Biosample/Treatment: cell line, RP96/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Ren H (2011) CST Curation Set: 11780; Year: 2011; Biosample/Treatment: cell line, RP97/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

74

Ren H (2011) CST Curation Set: 11781; Year: 2011; Biosample/Treatment: cell line, RP98/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Ren H (2011) CST Curation Set: 11783; Year: 2011; Biosample/Treatment: cell line, RP100/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Ren H (2011) CST Curation Set: 11784; Year: 2011; Biosample/Treatment: cell line, RP101/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

78

Ren H (2011) CST Curation Set: 11786; Year: 2011; Biosample/Treatment: cell line, RP103/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

79

Ren H (2011) CST Curation Set: 11787; Year: 2011; Biosample/Treatment: cell line, RP104/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Ren H (2011) CST Curation Set: 11788; Year: 2011; Biosample/Treatment: cell line, RP105/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Possemato A (2011) CST Curation Set: 11711; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Possemato A (2011) CST Curation Set: 11712; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Li Y (2011) CST Curation Set: 10458; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Li Y (2011) CST Curation Set: 10461; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Li Y (2011) CST Curation Set: 10516; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Li Y (2011) CST Curation Set: 10519; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

91

Li Y (2011) CST Curation Set: 10520; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

Li Y (2011) CST Curation Set: 10524; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

Li Y (2011) CST Curation Set: 10525; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Li Y (2011) CST Curation Set: 10527; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Possemato A (2011) CST Curation Set: 11628; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Possemato A (2011) CST Curation Set: 11632; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Tucker M (2011) CST Curation Set: 10943; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Tucker M (2011) CST Curation Set: 10945; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

Tucker M (2011) CST Curation Set: 10947; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

100

Tucker M (2011) CST Curation Set: 10949; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Tucker M (2011) CST Curation Set: 10951; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Tucker M (2011) CST Curation Set: 10952; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Tucker M (2011) CST Curation Set: 10954; Year: 2011; Biosample/Treatment: cell line, Jurkat/pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Ren H (2011) CST Curation Set: 11303; Year: 2011; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Li Y (2011) CST Curation Set: 10456; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Li Y (2011) CST Curation Set: 10451; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Moritz A (2011) CST Curation Set: 11304; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Moritz A (2011) CST Curation Set: 11305; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Moritz A (2011) CST Curation Set: 11306; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Moritz A (2011) CST Curation Set: 11307; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

Moritz A (2011) CST Curation Set: 11308; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Moritz A (2011) CST Curation Set: 11309; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Moritz A (2011) CST Curation Set: 11310; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Moritz A (2011) CST Curation Set: 11311; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Moritz A (2011) CST Curation Set: 11312; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Gu TL, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
21253578   Curated Info

117

Gu TL, et al. (2011) Survey of activated FLT3 signaling in leukemia. PLoS One 6, e19169
21552520   Curated Info

118

Ren H (2010) CST Curation Set: 10743; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Ren H (2010) CST Curation Set: 10744; Year: 2010; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Ren H (2010) CST Curation Set: 10740; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Ren H (2010) CST Curation Set: 10741; Year: 2010; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Ren H (2010) CST Curation Set: 10742; Year: 2010; Biosample/Treatment: cell line, RMUG-S/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Guo A (2010) CST Curation Set: 10556; Year: 2010; Biosample/Treatment: cell line, SH-SY5Y/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

Guo A (2010) CST Curation Set: 10557; Year: 2010; Biosample/Treatment: cell line, SH-SY5Y/NGF; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Guo A (2010) CST Curation Set: 10553; Year: 2010; Biosample/Treatment: cell line, SMS-KCN-A/untreated; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

Guo A (2010) CST Curation Set: 10551; Year: 2010; Biosample/Treatment: cell line, SKNBE(2)/NGF; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

Guo A (2010) CST Curation Set: 10549; Year: 2010; Biosample/Treatment: cell line, SKNBE(2)/NGF; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

Guo A (2010) CST Curation Set: 10548; Year: 2010; Biosample/Treatment: cell line, SKNBE(2)/NGF; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

Xiao K, et al. (2010) Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci U S A 107, 15299-304
20686112   Curated Info

130

Tucker M (2010) CST Curation Set: 10314; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

Ren H (2010) CST Curation Set: 10221; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

132

Ren H (2010) CST Curation Set: 10216; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

133

Ren H (2010) CST Curation Set: 10180; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

134

Ren H (2010) CST Curation Set: 10214; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

135

Ren H (2010) CST Curation Set: 10132; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

136

Rikova K (2010) CST Curation Set: 10042; Year: 2010; Biosample/Treatment: cell line, DFCI ERC17 serum free/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

137

Rikova K (2010) CST Curation Set: 10030; Year: 2010; Biosample/Treatment: cell line, HCC827/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

138

Moritz A (2010) CST Curation Set: 9800; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

139

Moritz A (2010) CST Curation Set: 9801; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

140

Moritz A (2010) CST Curation Set: 9798; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

141

Moritz A (2010) CST Curation Set: 9799; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

142

Moritz A (2010) CST Curation Set: 9788; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

143

Moritz A (2010) CST Curation Set: 9789; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

144

Moritz A (2010) CST Curation Set: 9787; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

Moritz A (2010) CST Curation Set: 9790; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

Moritz A (2010) CST Curation Set: 9687; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

Beausoleil S (2010) CST Curation Set: 9661; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

148

Beausoleil S (2010) CST Curation Set: 9662; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

149

Tucker M (2010) CST Curation Set: 9526; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

150

Tucker M (2010) CST Curation Set: 9528; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

151

Li J, et al. (2010) A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol 6, 291-9
20190765   Curated Info

152

Tucker M (2010) CST Curation Set: 9232; Year: 2010; Biosample/Treatment: cell line, Kyse520/untreated; Disease: esophageal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

153

Tucker M (2010) CST Curation Set: 9231; Year: 2010; Biosample/Treatment: cell line, Kyse510/untreated; Disease: esophageal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

154

Tucker M (2010) CST Curation Set: 9224; Year: 2010; Biosample/Treatment: cell line, Kyse70/untreated; Disease: esophageal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

155

Ren H (2010) CST Curation Set: 8898; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

Possemato A (2010) CST Curation Set: 8989; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

Possemato A (2010) CST Curation Set: 8938; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

Possemato A (2010) CST Curation Set: 8944; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

Possemato A (2010) CST Curation Set: 8941; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

160

Hu Y (2010) CST Curation Set: 8711; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

161

Possemato A (2010) CST Curation Set: 8940; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

162

Possemato A (2010) CST Curation Set: 8939; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

163

Hu Y (2010) CST Curation Set: 8712; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

164

Hu Y (2010) CST Curation Set: 8707; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

165

Hu Y (2010) CST Curation Set: 8708; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

166

Possemato A (2010) CST Curation Set: 8936; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

167

Possemato A (2010) CST Curation Set: 8942; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

168

Possemato A (2010) CST Curation Set: 8937; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991